Novartis AG (NVS)

Healthcare · Drug Manufacturers General · NYSE

Novartis AG (NVS) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $268.53B, a trailing price-to-earnings ratio of 16.9 and a free-cash-flow yield of 5.5%. Over the most recent reported fiscal year, revenue grew 9.6% and free cash flow per share grew 14.9%.

Market cap	$268.53B
Trailing P/E	16.9
FCF yield	5.5%
Revenue growth (YoY)	+9.6%
EPS growth (YoY)	+15.0%
FCF/share growth (YoY)	+14.9%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers General

Explore live NVS data on Nama Insights →

Recent Congressional trades

Novartis AG trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$15,001 - $50,000	Jul 21, 2026
Alan Armstrong	Senate	Buy	$15,001 - $50,000	Jul 21, 2026
Lisa McClain	House	Sell	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Nov 21, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Oct 22, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Oct 22, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Aug 13, 2025
Lisa McClain	House	Sell	$1,001 - $15,000	Aug 13, 2025